Sagimet Biosciences (SGMT) Reiterated at Market Outperform by Citizens

March 12, 2026 5:30 AM

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $35.00 price target on Sagimet Biosciences Inc (NASDAQ: SGMT).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found